0001179110-21-001126.txt : 20210202 0001179110-21-001126.hdr.sgml : 20210202 20210202202653 ACCESSION NUMBER: 0001179110-21-001126 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210129 FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAGNONI PABLO J CENTRAL INDEX KEY: 0001205703 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38586 FILM NUMBER: 21583749 MAIL ADDRESS: STREET 1: ONYX PHARMACEUTICALS, INC. STREET 2: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rubius Therapeutics, Inc. CENTRAL INDEX KEY: 0001709401 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042688109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-679-9600 MAIL ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2021-01-29 0 0001709401 Rubius Therapeutics, Inc. RUBY 0001205703 CAGNONI PABLO J C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 1 1 0 0 CEO and President Stock Option (Right to Buy) 11.97 2021-01-29 4 A 0 375000 0 A 2031-01-28 Common Stock 375000 375000 D Restricted Stock Units 2021-01-29 4 A 0 85000 0 A Common Stock 85000 85000 D 25% of this option shall vest on January 29, 2022, then in 12 equal quarterly installments thereafter. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The shares underlying the restricted stock units will vest in four equal annual installments beginning on January 29, 2022. /s/ Joanne M. Protano, Attorney-in-Fact 2021-02-02